These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 39080260

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. HMGA1 drives chemoresistance in esophageal squamous cell carcinoma by suppressing ferroptosis.
    Yang JY, Lei XY, He KY, Guo JR, Liu MJ, Li JQ, Li QT, Jiang ZH, Zhang L, Wu DH, Li YJ, Sun QH, Jian YP, Xu ZX.
    Cell Death Dis; 2024 Feb 21; 15(2):158. PubMed ID: 38383528
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CircDUSP16 Contributes to Cell Development in Esophageal Squamous Cell Carcinoma by Regulating miR-497-5p/TKTL1 Axis.
    Ma L, Li H, Lin Y, Wang G, Xu Q, Chen Y, Xiao K, Rao X.
    J Surg Res; 2021 Apr 21; 260():64-75. PubMed ID: 33326930
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. TKTL1 expression and its downregulation is implicated in cell proliferation inhibition and cell cycle arrest in esophageal squamous cell carcinoma.
    Shi Z, Tang Y, Li K, Fan Q.
    Tumour Biol; 2015 Nov 21; 36(11):8519-29. PubMed ID: 26032094
    [Abstract] [Full Text] [Related]

  • 8. Novel transketolase inhibitor oroxylin A suppresses the non-oxidative pentose phosphate pathway and hepatocellular carcinoma tumour growth in mice and patient-derived organoids.
    Jia D, Liu C, Zhu Z, Cao Y, Wen W, Hong Z, Liu Y, Liu E, Chen L, Chen C, Gu Y, Jiao B, Chai Y, Wang HY, Fu J, Chen X.
    Clin Transl Med; 2022 Nov 21; 12(11):e1095. PubMed ID: 36314067
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Epigenetic silencing of ZNF132 mediated by methylation-sensitive Sp1 binding promotes cancer progression in esophageal squamous cell carcinoma.
    Jiang D, He Z, Wang C, Zhou Y, Li F, Pu W, Zhang X, Feng X, Zhang M, Yecheng X, Xu Y, Jin L, Guo S, Wang J, Wang M.
    Cell Death Dis; 2018 Dec 18; 10(1):1. PubMed ID: 30578410
    [Abstract] [Full Text] [Related]

  • 13. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
    Guo JC, Xie YM, Ran LQ, Cao HH, Sun C, Wu JY, Wu ZY, Liao LD, Zhao WJ, Fang WK, Li EM, Xu LY, Schachner M, Xie JJ.
    J Mol Med (Berl); 2017 Dec 18; 95(12):1355-1368. PubMed ID: 28939985
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. GTF2E2 is a novel biomarker for recurrence after surgery and promotes progression of esophageal squamous cell carcinoma via miR-139-5p/GTF2E2/FUS axis.
    Zhang Y, Zhang Y, Ai B, Gong J, Li Y, Yu S, Cai X, Zhang L.
    Oncogene; 2022 Feb 18; 41(6):782-796. PubMed ID: 34853466
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD.
    Yang F, Sun Z, Wang D, Du T.
    BMC Cancer; 2022 Mar 22; 22(1):308. PubMed ID: 35317779
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.